511 related articles for article (PubMed ID: 23916290)
21. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
[TBL] [Abstract][Full Text] [Related]
22. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
23. Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.
Zinzani PL; Pellegrini C; Broccoli A; Casadei B; Argnani L; Pileri S
Am J Hematol; 2013 Nov; 88(11):E273-6. PubMed ID: 23843267
[TBL] [Abstract][Full Text] [Related]
24. BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
van Oers MH; Tönnissen E; Van Glabbeke M; Giurgea L; Jansen JH; Klasa R; Marcus RE; Wolf M; Kimby E; Vranovsky A; Holte H; Hagenbeek A; van der Reijden BA
J Clin Oncol; 2010 May; 28(13):2246-52. PubMed ID: 20368567
[TBL] [Abstract][Full Text] [Related]
25. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
26. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
[TBL] [Abstract][Full Text] [Related]
27. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
Mahé B; Milpied N; Mellerin MP; Moreau P; Morineau N; Vigier M; Harousseau JL
Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
[TBL] [Abstract][Full Text] [Related]
28. Follicular lymphoma of the duodenum: a clinicopathologic analysis of 26 cases.
Sentani K; Maeshima AM; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Jpn J Clin Oncol; 2008 Aug; 38(8):547-52. PubMed ID: 18687756
[TBL] [Abstract][Full Text] [Related]
29. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
[TBL] [Abstract][Full Text] [Related]
30. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
Masir N; Jones M; Abdul-Rahman F; Florence CS; Mason DY
Pathology; 2012 Apr; 44(3):228-33. PubMed ID: 22406486
[TBL] [Abstract][Full Text] [Related]
31. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
[TBL] [Abstract][Full Text] [Related]
32. Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.
Villa D; Crump M; Panzarella T; Savage KJ; Toze CL; Stewart DA; MacDonald DA; Buckstein R; Lee C; Alzahrani M; Rubinger M; Foley R; Xenocostas A; Sabloff M; Muccilli A; Chua N; Couture F; Larouche JF; Cohen S; Connors JM; Ambler K; Al-Tourah A; Ramadan KM; Kuruvilla J
J Clin Oncol; 2013 Mar; 31(9):1164-71. PubMed ID: 23401459
[TBL] [Abstract][Full Text] [Related]
33. bcl-2 and p53 protein expression in follicular lymphoma.
Cooper K; Haffajee Z
J Pathol; 1997 Jul; 182(3):307-10. PubMed ID: 9349233
[TBL] [Abstract][Full Text] [Related]
34. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.
Pham-Ledard A; Cowppli-Bony A; Doussau A; Prochazkova-Carlotti M; Laharanne E; Jouary T; Belaud-Rotureau MA; Vergier B; Merlio JP; Beylot-Barry M
Am J Clin Pathol; 2015 Mar; 143(3):362-73. PubMed ID: 25696794
[TBL] [Abstract][Full Text] [Related]
36. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
Horn H; Schmelter C; Leich E; Salaverria I; Katzenberger T; Ott MM; Kalla J; Romero M; Siebert R; Rosenwald A; Ott G
Haematologica; 2011 Sep; 96(9):1327-34. PubMed ID: 21659362
[TBL] [Abstract][Full Text] [Related]
37. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.
Wahlin BE; Yri OE; Kimby E; Holte H; Delabie J; Smeland EB; Sundström C; Christensson B; Sander B
Br J Haematol; 2012 Jan; 156(2):225-33. PubMed ID: 22126847
[TBL] [Abstract][Full Text] [Related]
39. Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis.
Sekiguchi N; Kobayashi Y; Yokota Y; Kusumoto S; Tanimoto K; Watanabe T; Matsuno Y; Tobinai K
Cancer Sci; 2005 Feb; 96(2):77-82. PubMed ID: 15723651
[TBL] [Abstract][Full Text] [Related]
40. Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses.
Pan Y; Meng B; Sun B; Guan B; Liang Y; Wang H; Hao X; Fu K
Diagn Mol Pathol; 2012 Dec; 21(4):234-40. PubMed ID: 22968395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
